Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recombinant Zoster Vaccine”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07293065
What this trial is testing

A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 12,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148
What this trial is testing

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster (HZ)ShinglesVZV+1 more
Guangzhou Patronus Biotech Co., Ltd. 840
Large-scale testing (Phase 3)Looking for participantsNCT04128189
What this trial is testing

Shingrix in Renal Transplant Recipients

Who this might be right for
Kidney Transplant Recipient Response to Shingrix VaccineKidney FailureKidney Failure, Chronic+2 more
University of Colorado, Denver 132
Not applicableEnded earlyNCT03993717
What this trial is testing

Solid Organ Transplant SHINGRIX

Who this might be right for
Kidney Transplant; Complications
Emory University 2
Very early researchStudy completedNCT03771157
What this trial is testing

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Waldenstrom Macroglobulinemia (WM)
University of Rochester 33
Testing effectiveness (Phase 2)Study completedNCT04047979
What this trial is testing

Systems Biology of Zoster Vaccine

Who this might be right for
ZosterZoster VaricellaShingles+1 more
Emory University 38
Testing effectiveness (Phase 2)Looking for participantsNCT07527247
What this trial is testing

Improving Vaccine Protection for Older Adults

Who this might be right for
Immune System Responses and Trained Immunity After AS01 AdministrationHealthy Adult
Singapore General Hospital 40
Early research (Phase 1)Study completedNCT02114333
What this trial is testing

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Who this might be right for
ShinglesHerpes Zoster
University of Colorado, Denver 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485283
What this trial is testing

Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia

Who this might be right for
Cardiovascular DiseaseDementia
Tor Biering-Sørensen 162,000
Early research (Phase 1)UnknownNCT05750017
What this trial is testing

Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Who this might be right for
Herpes ZosterVaccine-Preventable Diseases
Beijing Luzhu Biotechnology Co., Ltd. 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT05856084
What this trial is testing

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 924
Post-approval studies (Phase 4)Looking for participantsNCT07280741
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators

Who this might be right for
Autoimmune Rheumatic Diseases
University of Sao Paulo General Hospital 200
Post-approval studies (Phase 4)Study completedNCT05007041
What this trial is testing

Simultaneous RZV and aIIV4 Vaccination

Who this might be right for
PainQuality of LifeInjection Site Reaction+1 more
Duke University 267
Large-scale testing (Phase 3)Active Not RecruitingNCT06447779
What this trial is testing

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 25,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT06162494
What this trial is testing

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

Who this might be right for
Varicella Zoster
Ann & Robert H Lurie Children's Hospital of Chicago 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06654700
What this trial is testing

Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 1,200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07502560
What this trial is testing

Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Who this might be right for
Herpes Zoster
GlaxoSmithKline 33,609
Testing effectiveness (Phase 2)Looking for participantsNCT06932523
What this trial is testing

Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals

Who this might be right for
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products 645
Post-approval studies (Phase 4)Active Not RecruitingNCT05898464
What this trial is testing

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Who this might be right for
Vaccination; InfectionVaccine Adverse Reaction
Seoul National University Hospital 150
Not applicableLooking for participantsNCT07321808
What this trial is testing

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

Who this might be right for
Immunocompromised Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 300
Load More Results